Kim et al. [220] demonstrated that CD166 exhibited CSC-like properties in primary epithelial ovarian cancer cells and promoted the expression of CSC markers, including OCT4, SOX2, and ALDH1A1, as well as ABC transporters. This evidence concerns the gene ALDH1A1 and ovarian carcinoma.